Radiance has been selected to Present at the 2025 Biotech Showcase™ Alongside the J.P. Morgan Healthcare Conference

BOSTON, Jan. 15, 2025 (GLOBE NEWSWIRE) -- Radiance Biopharma, Inc. a biotechnology company developing next generation Antibody Drug Conjugates (“ADCs”) and Bispecific ADCs (“BsADCs), announced that it has been selected to participate in Seed Showcase, part of Biotech Showcase™ 2025. Radiance will also be available virtually through the RESI JPM 2025 and Bio Partnering @JPM Week portals. “We are delighted to announce that Radiance Biopharma was chosen to present at Biotech Showcase 2025 in San Francisco,” sa ...